Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.61
(0.18%)
HKD 5.61
(0.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.28 Billion CNY | 0.25% |
| 2022 | 8.26 Billion CNY | 12.73% |
| 2021 | 7.33 Billion CNY | 3.37% |
| 2020 | 7.09 Billion CNY | 10.21% |
| 2019 | 6.43 Billion CNY | 8.79% |
| 2018 | 5.91 Billion CNY | 12.18% |
| 2017 | 5.27 Billion CNY | 11.66% |
| 2016 | 4.72 Billion CNY | 5.13% |
| 2015 | 4.49 Billion CNY | 5.82% |
| 2014 | 4.24 Billion CNY | 10.28% |
| 2013 | 3.84 Billion CNY | 6.09% |
| 2012 | 3.62 Billion CNY | 20.77% |
| 2011 | 3 Billion CNY | 9.66% |
| 2010 | 2.73 Billion CNY | 4.32% |
| 2009 | 2.62 Billion CNY | 21.49% |
| 2008 | 2.16 Billion CNY | -4.8% |
| 2007 | 2.27 Billion CNY | 20.78% |
| 2006 | 1.88 Billion CNY | -14.82% |
| 2005 | 2.2 Billion CNY | -3.98% |
| 2004 | 2.29 Billion CNY | 10.22% |
| 2003 | 2.08 Billion CNY | 9.44% |
| 2002 | 1.9 Billion CNY | 3.74% |
| 2001 | 1.83 Billion CNY | 34.78% |
| 2000 | 1.36 Billion CNY | -1.56% |
| 1999 | 1.38 Billion CNY | 6.43% |
| 1998 | 1.3 Billion CNY | 6.84% |
| 1997 | 1.21 Billion CNY | 0.43% |
| 1996 | 1.21 Billion CNY | 44.48% |
| 1995 | 838.95 Million CNY | 4.07% |
| 1994 | 806.14 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 8.46 Billion CNY | 2.19% |
| 2024 Q3 | 8.82 Billion CNY | 1.04% |
| 2024 Q2 | 8.73 Billion CNY | 3.14% |
| 2023 FY | 8.28 Billion CNY | 0.25% |
| 2023 Q1 | 7.97 Billion CNY | -3.49% |
| 2023 Q2 | 8.07 Billion CNY | 1.24% |
| 2023 Q4 | 8.28 Billion CNY | 4.6% |
| 2023 Q3 | 7.92 Billion CNY | -1.9% |
| 2022 FY | 8.26 Billion CNY | 12.73% |
| 2022 Q1 | 7.67 Billion CNY | 4.67% |
| 2022 Q4 | 8.26 Billion CNY | 0.86% |
| 2022 Q2 | 7.94 Billion CNY | 3.55% |
| 2022 Q3 | 8.19 Billion CNY | 3.13% |
| 2021 FY | 7.33 Billion CNY | 3.37% |
| 2021 Q1 | 7.27 Billion CNY | 2.63% |
| 2021 Q2 | 7.27 Billion CNY | -0.11% |
| 2021 Q3 | 7.18 Billion CNY | -1.13% |
| 2021 Q4 | 7.33 Billion CNY | 1.98% |
| 2020 Q4 | 7.09 Billion CNY | 5.93% |
| 2020 Q3 | 6.69 Billion CNY | -1.47% |
| 2020 Q2 | 6.79 Billion CNY | -3.53% |
| 2020 Q1 | 7.04 Billion CNY | 9.45% |
| 2020 FY | 7.09 Billion CNY | 10.21% |
| 2019 FY | 6.43 Billion CNY | 8.79% |
| 2019 Q1 | 6.04 Billion CNY | 2.09% |
| 2019 Q2 | 6.09 Billion CNY | 0.93% |
| 2019 Q3 | 6.04 Billion CNY | -0.77% |
| 2019 Q4 | 6.43 Billion CNY | 6.39% |
| 2018 Q2 | 5.67 Billion CNY | 4.6% |
| 2018 Q3 | 5.74 Billion CNY | 1.25% |
| 2018 FY | 5.91 Billion CNY | 12.18% |
| 2018 Q4 | 5.91 Billion CNY | 3.03% |
| 2018 Q1 | 5.42 Billion CNY | 2.82% |
| 2017 FY | 5.27 Billion CNY | 11.66% |
| 2017 Q4 | 5.27 Billion CNY | 2.03% |
| 2017 Q3 | 5.16 Billion CNY | 3.42% |
| 2017 Q2 | 4.99 Billion CNY | 3.11% |
| 2017 Q1 | 4.84 Billion CNY | 2.63% |
| 2016 FY | 4.72 Billion CNY | 5.13% |
| 2016 Q4 | 4.72 Billion CNY | 2.67% |
| 2016 Q1 | 4.5 Billion CNY | 0.32% |
| 2016 Q2 | 4.38 Billion CNY | -2.65% |
| 2016 Q3 | 4.59 Billion CNY | 4.85% |
| 2015 Q1 | 4.34 Billion CNY | 2.45% |
| 2015 Q4 | 4.49 Billion CNY | 1.19% |
| 2015 FY | 4.49 Billion CNY | 5.82% |
| 2015 Q3 | 4.43 Billion CNY | -1.11% |
| 2015 Q2 | 4.48 Billion CNY | 3.22% |
| 2014 Q1 | 3.83 Billion CNY | -0.3% |
| 2014 Q3 | 4.11 Billion CNY | 4.78% |
| 2014 Q4 | 4.24 Billion CNY | 3.06% |
| 2014 FY | 4.24 Billion CNY | 10.28% |
| 2014 Q2 | 3.93 Billion CNY | 2.44% |
| 2013 Q4 | 3.84 Billion CNY | 4.73% |
| 2013 FY | 3.84 Billion CNY | 6.09% |
| 2013 Q3 | 3.67 Billion CNY | 1.37% |
| 2013 Q2 | 3.62 Billion CNY | -2.49% |
| 2013 Q1 | 3.71 Billion CNY | 2.48% |
| 2012 FY | 3.62 Billion CNY | 20.77% |
| 2012 Q2 | 3.39 Billion CNY | -0.92% |
| 2012 Q1 | 3.43 Billion CNY | 14.18% |
| 2012 Q3 | 3.57 Billion CNY | 5.31% |
| 2012 Q4 | 3.62 Billion CNY | 1.38% |
| 2011 Q2 | 2.85 Billion CNY | 1.21% |
| 2011 FY | 3 Billion CNY | 9.66% |
| 2011 Q4 | 3 Billion CNY | -2.77% |
| 2011 Q3 | 3.08 Billion CNY | 8.33% |
| 2011 Q1 | 2.81 Billion CNY | 2.87% |
| 2010 Q2 | 2.79 Billion CNY | 1.54% |
| 2010 Q3 | 2.84 Billion CNY | 1.64% |
| 2010 Q4 | 2.73 Billion CNY | -3.6% |
| 2010 Q1 | 2.75 Billion CNY | 4.85% |
| 2010 FY | 2.73 Billion CNY | 4.32% |
| 2009 Q2 | 2.4 Billion CNY | 3.5% |
| 2009 FY | 2.62 Billion CNY | 21.49% |
| 2009 Q3 | 2.49 Billion CNY | 3.86% |
| 2009 Q1 | 2.32 Billion CNY | 7.48% |
| 2009 Q4 | 2.62 Billion CNY | 5.16% |
| 2008 Q2 | 2.13 Billion CNY | -1.92% |
| 2008 FY | 2.16 Billion CNY | -4.8% |
| 2008 Q1 | 2.17 Billion CNY | -4.3% |
| 2008 Q4 | 2.16 Billion CNY | -5.62% |
| 2008 Q3 | 2.29 Billion CNY | 7.47% |
| 2007 FY | 2.27 Billion CNY | 20.78% |
| 2007 Q3 | 2 Billion CNY | -1.71% |
| 2007 Q1 | 1.99 Billion CNY | 6.02% |
| 2007 Q2 | 2.04 Billion CNY | 2.37% |
| 2007 Q4 | 2.27 Billion CNY | 13.21% |
| 2006 Q2 | 2.04 Billion CNY | -7.9% |
| 2006 Q1 | 2.22 Billion CNY | 0.75% |
| 2006 Q4 | 1.88 Billion CNY | -12.94% |
| 2006 FY | 1.88 Billion CNY | -14.82% |
| 2006 Q3 | 2.15 Billion CNY | 5.45% |
| 2005 Q2 | 2.4 Billion CNY | 5.01% |
| 2005 Q4 | 2.2 Billion CNY | -3.85% |
| 2005 Q3 | 2.29 Billion CNY | -4.62% |
| 2005 Q1 | 2.29 Billion CNY | -0.28% |
| 2005 FY | 2.2 Billion CNY | -3.98% |
| 2004 Q4 | 2.29 Billion CNY | -2.53% |
| 2004 Q1 | 2.25 Billion CNY | 8.21% |
| 2004 Q3 | 2.35 Billion CNY | -1.5% |
| 2004 FY | 2.29 Billion CNY | 10.22% |
| 2004 Q2 | 2.39 Billion CNY | 6.09% |
| 2003 FY | 2.08 Billion CNY | 9.44% |
| 2003 Q1 | 1.97 Billion CNY | 3.46% |
| 2003 Q2 | 2.02 Billion CNY | 2.83% |
| 2003 Q3 | 2.13 Billion CNY | 5.21% |
| 2003 Q4 | 2.08 Billion CNY | -2.23% |
| 2002 Q3 | 1.89 Billion CNY | 1.38% |
| 2002 Q1 | 1.88 Billion CNY | 2.68% |
| 2002 FY | 1.9 Billion CNY | 3.74% |
| 2002 Q2 | 1.87 Billion CNY | -0.76% |
| 2002 Q4 | 1.9 Billion CNY | 0.42% |
| 2001 Q4 | 1.83 Billion CNY | 0.0% |
| 2001 Q2 | 1.42 Billion CNY | 0.0% |
| 2001 FY | 1.83 Billion CNY | 34.78% |
| 2000 FY | 1.36 Billion CNY | -1.56% |
| 2000 Q4 | 1.36 Billion CNY | 0.0% |
| 2000 Q2 | 1.46 Billion CNY | 0.0% |
| 1999 FY | 1.38 Billion CNY | 6.43% |
| 1999 Q4 | 1.38 Billion CNY | 0.0% |
| 1999 Q2 | 1.39 Billion CNY | 0.0% |
| 1998 Q4 | 1.3 Billion CNY | 0.0% |
| 1998 FY | 1.3 Billion CNY | 6.84% |
| 1998 Q2 | 1.25 Billion CNY | 0.0% |
| 1997 Q4 | 1.21 Billion CNY | 0.0% |
| 1997 FY | 1.21 Billion CNY | 0.43% |
| 1997 Q2 | 1.22 Billion CNY | 0.0% |
| 1996 FY | 1.21 Billion CNY | 44.48% |
| 1996 Q4 | 1.21 Billion CNY | 0.0% |
| 1995 FY | 838.95 Million CNY | 4.07% |
| 1994 FY | 806.14 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -813.111% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 63.198% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -543.741% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -295.5% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -1633.083% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -186.652% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -193.05% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -379.708% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -881.816% |
| SSY Group Limited | 11.96 Billion HKD | 30.754% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -496.686% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -137.64% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 96.95% |